Human Genome Sciences And Xencor Announce Antibody Collaboration Read more about Human Genome Sciences And Xencor Announce Antibody Collaboration
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma Read more about Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma
Xencor Appoints Industry Veteran David R. King as Chairman of its Board of Directors Read more about Xencor Appoints Industry Veteran David R. King as Chairman of its Board of Directors
Xencor Presents Pre-Clinical Data for Anti-CD19 Antibody at AACR Read more about Xencor Presents Pre-Clinical Data for Anti-CD19 Antibody at AACR
Xencor to Present New Data from Anti-CD19 Antibody Program at ASCO Read more about Xencor to Present New Data from Anti-CD19 Antibody Program at ASCO
Xencor to Present New Data from Pre-Clinical Antibody Programs at Upcoming ASH Conference Read more about Xencor to Present New Data from Pre-Clinical Antibody Programs at Upcoming ASH Conference
Xencor Presents Data from Pre-clinical Studies of its Anti-CD19 and Anti-CD40 Antibodies at the 50th Annual Meeting of the American Society of Hematology Read more about Xencor Presents Data from Pre-clinical Studies of its Anti-CD19 and Anti-CD40 Antibodies at the 50th Annual Meeting of the American Society of Hematology
Xencor and CSL Limited Establish Antibody Optimization Collaboration Read more about Xencor and CSL Limited Establish Antibody Optimization Collaboration
Xencor and Pfizer enter into Antibody Technology Licensing Agreement Read more about Xencor and Pfizer enter into Antibody Technology Licensing Agreement
Xencor Presents Preliminary Phase 1 Data on XmAb®2513 Antibody for Lymphomas at 2009 American Society of Clinical Oncology Annual Meeting Read more about Xencor Presents Preliminary Phase 1 Data on XmAb®2513 Antibody for Lymphomas at 2009 American Society of Clinical Oncology Annual Meeting
